Zacks Investment Research
29 Jul 2026, 18:40 UTC · 8w ago
Verdict
Headline leans bearish. We score UTMD −0.30 across four claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−0.30moderately bearish
What the story claims
4 claims · scored −1 bearish … +1 bullish
Utah Medical Products (UTMD) reported a 14.3% year-over-year decline in second-quarter 2026 revenues to $8.5 million.
So whatSignificant revenue contraction usually signals weakening demand or loss of market share, negatively impacting valuation.
More negative than 86% of claims this week
UTMD's diluted earnings per share (EPS) decreased 10.1% year-over-year to 84.4 cents.
Continue reading
5 related stories
More negative than 70% of ticker scores this week
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More negative than 78% of claims this week
The revenue decline was primarily driven by the total loss of sales from two major former customers, including PendoTECH and a China-based distributor.
So whatThe loss of key accounts creates a structural hole in revenue that requires new customer acquisition to fill.
More negative than 78% of claims this week
UTMD maintained a gross margin of 55.8%, only a slight contraction from 56.2% in the prior-year quarter.
So whatStability in margins despite falling revenue suggests the company has decent pricing power or cost control.
More positive than 51% of claims this week
Which stocks this story touches
More negative than 70% of ticker scores this week
The company reported declines in EPS, revenues, and net income, primarily due to the loss of major customers.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
+5.3%
Price is moving against the score
$74.75 vs $70.96 close before publication (Jul 28) · not market-adjusted
UTMD chart →